196 related articles for article (PubMed ID: 35203414)
1. VEGF-Trap Modulates Retinal Inflammation in the Murine Oxygen-Induced Retinopathy (OIR) Model.
Rojo Arias JE; Englmaier VE; Jászai J
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203414
[TBL] [Abstract][Full Text] [Related]
2. VEGF-Trap is a potent modulator of vasoregenerative responses and protects dopaminergic amacrine network integrity in degenerative ischemic neovascular retinopathy.
Rojo Arias JE; Economopoulou M; Juárez López DA; Kurzbach A; Au Yeung KH; Englmaier V; Merdausl M; Schaarschmidt M; Ader M; Morawietz H; Funk RHW; Jászai J
J Neurochem; 2020 May; 153(3):390-412. PubMed ID: 31550048
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profile of the murine ischemic retina and its response to Aflibercept (VEGF-Trap).
Rojo Arias JE; Jászai J
Sci Rep; 2021 Jul; 11(1):15313. PubMed ID: 34321516
[TBL] [Abstract][Full Text] [Related]
4. Melatonin attenuated retinal neovascularization and neuroglial dysfunction by inhibition of HIF-1α-VEGF pathway in oxygen-induced retinopathy mice.
Xu Y; Lu X; Hu Y; Yang B; Tsui CK; Yu S; Lu L; Liang X
J Pineal Res; 2018 May; 64(4):e12473. PubMed ID: 29411894
[TBL] [Abstract][Full Text] [Related]
5. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of CCN1-enhanced retinal neovascularization in oxygen-induced retinopathy through PI3K/Akt-VEGF signaling pathway.
Di Y; Zhang Y; Yang H; Wang A; Chen X
Drug Des Devel Ther; 2015; 9():2463-73. PubMed ID: 25995618
[TBL] [Abstract][Full Text] [Related]
7. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.
Wang H; Yang Z; Jiang Y; Hartnett ME
Mol Vis; 2014; 20():231-41. PubMed ID: 24623966
[TBL] [Abstract][Full Text] [Related]
8. Selective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR).
Vähätupa M; Salonen N; Uusitalo-Järvinen H; Järvinen TAH
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834347
[TBL] [Abstract][Full Text] [Related]
9. Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog.
Lutty GA; McLeod DS; Bhutto I; Wiegand SJ
Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4039-47. PubMed ID: 21357392
[TBL] [Abstract][Full Text] [Related]
10. Galectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGF.
Ridano ME; Subirada PV; Paz MC; Lorenc VE; Stupirski JC; Gramajo AL; Luna JD; Croci DO; Rabinovich GA; Sánchez MC
Oncotarget; 2017 May; 8(20):32505-32522. PubMed ID: 28455954
[TBL] [Abstract][Full Text] [Related]
11. SWATH-MS Proteomic Analysis of Oxygen-Induced Retinopathy Reveals Novel Potential Therapeutic Targets.
Vähätupa M; Nättinen J; Jylhä A; Aapola U; Kataja M; Kööbi P; Järvinen TAH; Uusitalo H; Uusitalo-Järvinen H
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3294-3306. PubMed ID: 30025079
[TBL] [Abstract][Full Text] [Related]
12. Temporal and spatial changes in VEGF, αA- and αB-crystallin expression in a mouse model of oxygen-induced retinopathy.
Shi Y; Su C; Wang JT; Du B; Dong LJ; Liu AH; Li XR
Int J Clin Exp Med; 2015; 8(3):3349-59. PubMed ID: 26064225
[TBL] [Abstract][Full Text] [Related]
13. Exploration of Oxygen-Induced Retinopathy Model to Discover New Therapeutic Drug Targets in Retinopathies.
Vähätupa M; Järvinen TAH; Uusitalo-Järvinen H
Front Pharmacol; 2020; 11():873. PubMed ID: 32595503
[TBL] [Abstract][Full Text] [Related]
14. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
Han N; Xu H; Yu N; Wu Y; Yu L
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the Nuclear Receptor RORγ and Interleukin-17A Suppresses Neovascular Retinopathy: Involvement of Immunocompetent Microglia.
Talia DM; Deliyanti D; Agrotis A; Wilkinson-Berka JL
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1186-96. PubMed ID: 27055905
[TBL] [Abstract][Full Text] [Related]
16. Effect of Autophagy Modulators on Vascular, Glial, and Neuronal Alterations in the Oxygen-Induced Retinopathy Mouse Model.
Subirada PV; Paz MC; Ridano ME; Lorenc VE; Fader CM; Chiabrando GA; Sánchez MC
Front Cell Neurosci; 2019; 13():279. PubMed ID: 31297049
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat.
van Wijngaarden P; Brereton HM; Gibbins IL; Coster DJ; Williams KA
Exp Eye Res; 2007 Oct; 85(4):508-17. PubMed ID: 17692314
[TBL] [Abstract][Full Text] [Related]
18. Effects and Mechanism of Action of PX-478 in Oxygen-Induced Retinopathy in Mice.
Pan X; Lv Y
Ophthalmic Res; 2020; 63(2):182-193. PubMed ID: 31955159
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model.
Zhang J; Zhu M; Ruan L; Jiang C; Yang Q; Chang Q; Huang X
FASEB J; 2020 Dec; 34(12):15822-15836. PubMed ID: 33103304
[TBL] [Abstract][Full Text] [Related]
20. Anti-Vascular Endothelial Growth Factor Agents in the Treatment of Retinal Disease: From Bench to Bedside.
Campochiaro PA; Aiello LP; Rosenfeld PJ
Ophthalmology; 2016 Oct; 123(10S):S78-S88. PubMed ID: 27664289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
